Livo Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 5200.92%
- Profit Growth 172.33%
- Ebitda 91.70%
- Net Worth 42.48%
- Total Assets 190.19%
About Livo Pharmaceutical
Livo Pharmaceutical Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 June 2020 (Four years and eight months 4 days old ). Its registered office is in Bhagalpur, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nikita Sodhi, Poonam Kumari, Punpun Kumari, and One other member serve as directors at the Company.
Company Details
- Location
Bhagalpur, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304BR2020PTC046447
- Company No.
046447
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Livo Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikita Sodhi  | Director | 22-Jun-2020 | Current |
| Poonam Kumari | Director | 22-Jun-2020 | Current |
| Punpun Kumari | Director | 30-Sep-2021 | Current |
| Kalyani Kumari | Director | 30-Sep-2021 | Current |
Financial Performance of Livo Pharmaceutical.
Livo Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 5200.92% increase. The company also saw a substantial improvement in profitability, with a 172.33% increase in profit. The company's net worth Soared by an impressive increase of 42.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Livo Pharmaceutical?
Unlock access to Livo Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Livo Pharmaceutical?
Livo Pharmaceutical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Livo Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Livo Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.